{"id":"W4402006334","doi":"10.1183/13993003.01205-2024","title":"Clinical trial design, end-points, and emerging therapies in pulmonary arterial hypertension","year":2024,"lang":"en","type":"review","venue":"European Respiratory Journal","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"National Heart, Lung, and Blood Institute; British Heart Foundation; Acceleron; United Therapeutics Corporation; National Institute of Allergy and Infectious Diseases; Pfizer","keywords":"Medicine; Pulmonary hypertension; Clinical trial; Intensive care medicine; Cardiology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02590923,0.0009944456,0.004130548,0.002441322,0.0003691863,0.002363502,0.002025124,0.003284317,0.002347143],"category_scores_gemma":[0.03035388,0.0004854003,0.002356956,0.003108362,0.001529056,0.001653146,0.001132166,0.004571166,0.0006434351],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00187499,"about_ca_system_score_gemma":0.004688088,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001247432,"about_ca_topic_score_gemma":0.002055148,"domain_scores_codex":[0.9816346,0.01253781,0.002336497,0.0007265986,0.002507654,0.0002568951],"domain_scores_gemma":[0.9590638,0.03600548,0.002125872,0.0004718284,0.002062107,0.0002708588],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004770848,0.00006522024,0.0002322989,0.08764617,0.001196335,0.00006199404,0.0001019821,0.0006666265,0.0003153014,0.01332383,0.0140729,0.8818403],"study_design_scores_gemma":[0.001496861,0.001110161,0.003457272,0.1751543,0.005984478,0.0009150681,0.0002193049,0.001085131,0.0007490216,0.03367747,0.7760275,0.0001233097],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004794077,0.9986753,0.0002956156,0.0004756261,0.000218587,0.0000398231,0.00001279037,0.000003855951,0.000230388],"genre_scores_gemma":[0.002086739,0.9940326,0.00154307,0.001430511,0.0003573321,0.0002650202,0.00004344528,0.00000553051,0.0002358305],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02590923,"threshold_uncertainty_score":0.1370227,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2423984228353526,"score_gpt":0.4235427001234912,"score_spread":0.1811442772881386,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}